Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases

Novel hydantoin derivatives have the following general formula (I): wherein A represents an oxygen or sulfur atom or the group B(CH2)pY in which B is CH or N, Y is a hydrogen atom, an aromatic ring or an alkyl or alkenoyl group, which may or may not be substituted by an aromatic ring, and p is 0, 1,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HAYASHI, MOTOHIDE, SANWA KAGAKU, KENKYUSHO CO.LTD, KONDO, YASUAKI, SANWA KAGAKU, KENKYUSHO CO.LTD, KURONO, MASAYASU, SANWA KAGAKU, KENKYUSHO CO.LTD, NAKAMURA, SHIGEYOSHI, SANWA KAGAKU, KENKYUSHO CO, TANAKA, YUKIYA, SANWA KAGAKU, KENKYUSHO CO.LTD, USUI, TOSHINAO, SANWA KAGAKU, KENKYUSHO CO.LTD, MIURA, KENJI, SANWA KAGAKU, KENKYUSHO CO.LTD, SUZUKI, TUNEMASA, SANWA KAGAKU, KENKYUSHO CO.LTD, TOMIYA, NOBORU, SANWA KAGAKU, KENKYUSHO CO.LTD, SAWAI, KIICHI, SANWA KAGAKU, KENKYUSHO CO.LTD
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Novel hydantoin derivatives have the following general formula (I): wherein A represents an oxygen or sulfur atom or the group B(CH2)pY in which B is CH or N, Y is a hydrogen atom, an aromatic ring or an alkyl or alkenoyl group, which may or may not be substituted by an aromatic ring, and p is 0, 1, 2 or 3, X represents a halogen atom, and m and n, which may be identical or different, are each 1, 2 or 3. The components (I) and their salts are efficacious against diabetic complications and circulatory organ diseases.